Pain Status of Healthcare Workers after COVID-19

Abstract

Objective: The aim of the study; it is the investigation of pain status in healthcare workers who are at high risk after COVID-19. Methods: A total of 180 healthcare professionals aged 18-65 years who had COVID-19 and were not COVID-19 participated in the study. Data were collected between February and May 2021. During the data collection phase, the "Preliminary Evaluation Form" and the "McGill- Melzack pain Questionnaire (MPQ)", which includes demographic information and information about the COVID-19 situation, were used. Results: It was found that there was no statistically significant difference between the pain questionnaire scale scores between the groups with and without COVID-19 (p=.951). It was determined that the scores of the health technicians were statistically lower than the scores of the nurses-midwives (p=.022). It was found that pain scores did not differ statistically significantly according to gender (p=.947). It has been observed that deep pain is mostly defined in the upper back (36.6%) and lower back (34.4%) region, and superficial pain is defined in the neck (31.1%) region in those who had COVID-19. Conclusion: As a results; In healthcare workers who have had COVID-19, pain was most common in the waist and back regions. Pain did not differ in terms of gender in those who have COVID-19, however, nurses-midwives experienced more pain than health technicians.

Keywords

• COVID-19
• Healthcare Professionals
• Pain

Sağlık Çalışanlarında COVID-19 Sonrası Ağrı Durumu

Abstract

Amaç: Çalışmanın amacı; COVID-19 sonrası yüksek risk altında olan sağlık çalışanlarında ağrı durumunun araştırılmasıdır. Yöntem: Çalışmaya 18-65 yaş arası COVID-19 geçiren ve COVID-19 geçirmeyen toplam 180 sağlık çalışanı katılmıştır. Veriler Şubat-Mayıs 2021 tarihleri arasında toplanmıştır. Veri toplama aşamasında demografik bilgileri ve COVID-19 durumuna ait bilgileri içeren “Ön Değerlendirme Formu” ve’’McGill-Melzack Ağrı Anketi (MAÖ)’’kullanılmıştır. Bulgular: Ağrı anketi ölçek skorlarının COVID-19 geçiren ve geçirmeyen gruplar arasında anlamlı düzeyde farklılaşmadığı bulunmuştur (p=,951). Sağlık teknisyenlerinin puanlarının, hemşirelerin-ebelerin puanlarına göre istatitiksel anlamda düşük olduğu saptanmıştır (p=,022). Ağrı skorlarının cinsiyete göre istatistiksel olarak anlamlı düzeyde farklılık göstermediği bulunmuştur (p=,947). COVID-19 geçirenlerde derin ağrının daha çok sırt (%36.6) ve bel (%34.4) bölgelerinde, yüzeysel ağrının ise boyun (%31,1) bölgesinde tanımlandığı görülmüştür. Sonuç: Sonuç olarak; COVID-19 geçiren sağlık çalışanlarında en çok bel ve sırt bölgelerinde ağrı görülmektedir. COVID-19 geçirenlerde cinsiyet açısından ağrı farklılık göstermediği ve sağlık teknisyenlerinin hemşirelere-ebelere göre daha az ağrı yaşadığı gösterilmiştir.

Keywords

• : COVID-19
• Sağlık Çalışanları
• Ağrı

References

1. 1. Rudberg, A. S., Havervall, S., Månberg, A., Jernbom Falk, A., Aguilera, K., Henry, Ng., et al. (2020). SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nature Communications 2020 11:1, 11(1), 1–8.
2. 2. Sim, M. R. (2020). The COVID-19 pandemic: major risks to healthcare and other workers on the front line. Occupational and Environmental Medicine, 77(5), 281–282.
3. 3. Gedefaw, L., Ullah, S., LeungORCID, P. H. M., Cai, Y., Yip, S.-P., & Huang, C.-L. (2021). Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients. Cells 2021, Vol. 10, Page 916, 10(4), 916.
4. 4. Sirisawasd, S., Taptagaporn, S., Boonshuyar, C., & Earde, P. (2018). Interventions commonly used to prevent work-related musculoskeletal disorders among healthcare workers. Journal of Health Research, 32(5), 371–383.
5. 5. Shields, A., Faustini, S. E., Perez-Toledo, M., Jossi, S., Aldera, E., Allen, J. D., et al. (2020). SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax, 75(12), 1089–1094.
6. 6. Martin, C. A., Patel, P., Goss, C., Jenkins, D. R., Price, A., Barton, L., et al. (2022). Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff. Journal of Public Health, 44(2), 234–245.
7. 7. Han, R., Huang, L., Jiang, H., Dong, J., Peng, H., Zhang, D. (2020). Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) Pneumonia. American Journal of Roentgenology. 215(2):338–43.
8. 8. Melzac, R. (1999). Pain Measurement in Persons in Pain. Textbook of Pain. 409–26.

9. 9. Wang, X., Liu, W., Zhao, J., Lu, Y., Yu, C., Hu, S., et al. (2020). Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China. Journal of Hospital Infection, 105(3), 399– 403.
10. 10. Jackson, D., Anders, R., Padula, W. V., Daly, J., & Davidson, P. M. (2020). Vulnerability of nurse and physicians with COVID‐19: Monitoring and surveillance needed. Journal of Clinical Nursing, 29(19–20), 3584.
11. 11. Carfì, A., Bernabei, R., & Landi, F. (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA, 324(6), 603–605.
12. 12. Meyer-Frießem, C. H., Gierthmühlen, J., Baron, R., Sommer, C., Üçeyler, N., & Enax-Krumova, E. K. (2021). Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge. Pain Reports, 6(1).
13. 13. Xu, T., Chen, C., Zhu, Z., Cui, M., Chen, C., Dai, H., & Xue, Y. (2020). Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19. International Journal of Infectious Diseases, 94, 68–71.
14. 14. Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., et al. (2021). Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China. Clinical Infectious Diseases, 73(11), e4208–e4213.
15. 15. Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., et al. (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino- Laryngology, 277(8), 2251–2261.
16. 16. Eren, F., Özkan, B., & Demir, A. (2021). Myalgia-arthralgia and Associated Factors in Patients with COVID- 19. Turk Noroloji Dergisi, 27(Suppl 1), 15–20.
17. 17. Toprak Celenay, S., Karaaslan, Y., Mete, O., & Ozer Kaya, D. (2020). Coronaphobia, musculoskeletal pain, and sleep quality in stay-at home and continued-working persons during the 3-month Covid-19 pandemic lockdown in Turkey. Chronobiology International The Journal of Biological and Medical Rhythm Research. 37(12):1778–85.
18. 18. Mirmohammadi, S., Yazdani, J., Etemadinejad, S., & Asgarinejad, H. (2015). A Cross-sectional Study on Work-related Musculoskeletal Disorders and Associated Risk Factors Among Hospital Health Cares. Procedia Manufacturing, 3, 4528–4534.
19. 19. Arca, M., Dönmezdil, S., & Durmaz, E. D. (2021). The effect of the COVID-19 Pandemic on anxiety, depression, and musculoskeletal system complaints in healthcare workers. Work, 69(1), 47–54.
20. 20. Mroczek, B., Łubkowska, W., Jarno, W., Jaraczewska, E., & Mierzecki, A. (2020). Occurrence and impact of back pain on the quality of life of healthcare workers. Annals of Agricultural and Environmental Medicine, 27(1), 36–42.
21. 21. Salaffi, F., Giorgi, V., Sirotti, S., Bongiovanni, S., Farah, S., Bazzichi, L., et al. (2021). The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clin Exp Rheumatol, 39(3), 72–77.
22. 22. Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, A. N., Funai, K., Mcdonagh, B., et al. (2019). Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis. The FASEB Journal, 33(7), 7863–7881.
23. 23. Griffith, J. F. (2011). Musculoskeletal complications of severe acute respiratory syndrome. Seminars in Musculoskeletal Radiology, 15(5), 554–560.
24. 24. Wang, C., Riyu, P., Xiaoyang, W., Yilin, T., Linkang, X., Cyrus, S. H., & C.H., R. (2020). Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. International Journal of Environmental Research and Public Health, 17(5), 1–25.
25. 25. Mangalmurti, N., & Hunter, C. A. (2020). Cytokine Storms: Understanding COVID-19. Immunity, 53(1), 19–25.
26. 26. Kemp, H. I., Corner, E., & Colvin, L. A. (2020). Chronic pain after COVID-19: implications for rehabilitation. British Journal of Anaesthesia, 125(4), 436–440.